REGN Operating Cash Flow

Regeneron Pharmaceuticals · Operating Cash Flow

REGN logo

REGN Operating Cash Flow

Latest reported$574.50M
REGN Quarterly Operating Cash Flow (-$2.70M → $574.50M)
High-resolution chart · PNG

REGN operating cash flow history

Quarterly · USD. Dates are reporting period ends; fiscal years can differ from calendar years.

Regeneron Pharmaceuticals Operating Cash Flow — Quarterly (USD)
Period endingOperating Cash Flow (USD)
574,500,000
1,078,900,000
1,170,700,000
1,618,700,000
1,144,400,000
1,045,100,000
1,262,800,000
1,291,200,000
354,000,000
1,512,500,000
1,089,700,000
1,114,300,000
1,022,400,000
1,367,600,000
1,719,900,000
628,900,000
564,400,000
2,101,700,000
2,372,500,000
3,413,600,000
626,700,000
668,500,000
1,231,000,000
-254,300,000
943,400,000
698,000,000
787,400,000
557,300,000
188,300,000
897,000,000
728,800,000
452,900,000
394,600,000
618,800,000
566,937,000
414,832,000
-30,570,000
355,901,000
377,879,000
651,029,000
399,499,000
44,989,000
281,823,000
892,853,000
257,831,000
-101,727,000
198,175,000
164,321,000
336,412,000
53,527,000
276,781,000
92,455,000
128,164,000
86,248,000
93,185,000
-2,382,000
-78,377,000
-87,041,000
-50,317,000
-46,735,000
-34,050,000
-10,580,000
-41,699,000
160,669,000
-12,625,000
-10,001,000
-46,404,000
-9,822,000
-5,805,000
-10,199,000
-35,840,000
-41,546,000
6,197,000
-17,897,000
50,817,000
-10,700,000
-3,507,000
-9,238,000
53,303,000
-14,831,000
-20,675,000
5,278,000
-19,847,000
-14,998,000
-28,583,000
33,132,000
-12,199,000
-3,586,000
17,458,000
-18,582,000
-28,429,000
61,810,000
-40,707,000
1,193,000
-31,026,000
-23,854,000
-29,589,000
-26,054,000
-17,654,000
-21,891,000
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.